Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132341) titled 'A Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial to Evaluate the Clinical Performance and Safety of an Ophthalmic Surgical System for Vitrectomy' on Sept. 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Tongren hospital,CMU
Condition:
Ocular fundus diseases
Intervention:
Intervention group:Vitrectomy-XR 1300
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-10
Target Sample Size: Intervention group:80;Control group:80;
Countries of Recruitment:
china
To know more, visit https://www.chictr.org.cn/showproj...